Pradyumna Agasthi, MBBS

Pradyumna Agasthi practices at Saint Francis Hospital Muskogee in Muskogee, Oklahoma, part of Saint Francis Health System.

Pradyumna Agasthi's NPI, 1184034134, was assigned on April 30, 2014. Pradyumna Agasthi holds Oklahoma license 44552.

Pradyumna Agasthi's primary practice is Saint Francis Hospital Muskogee, at 300 Rockefeller Drive, Muskogee, OK 74401 in Muskogee County. The practice phone is (918) 682-5501.

Pradyumna Agasthi's primary practice is Saint Francis Hospital Muskogee in Muskogee, Oklahoma, part of Saint Francis Health System. Pradyumna Agasthi is also affiliated with Saint Francis Hospital. The medical group on file is Warren Clinic. Dmand AI also links Pradyumna Agasthi to 3 more hospitals, 5 medical groups, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Pradyumna Agasthi practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Pradyumna Agasthi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Pradyumna Agasthi is licensed in Oklahoma.

CMS data shows 4,741 Medicare services from Pradyumna Agasthi across 35 procedure codes in 2024, for 2,096 Medicare patients. Medicare paid $222,139 for them.

CMS counts 2,096 Medicare patients who saw Pradyumna Agasthi in 2024. The largest group is 65 to 74, with 919 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Pradyumna Agasthi's median patient age at 70, with 54% women.

In 2024, Pradyumna Agasthi wrote 1,759 Medicare Part D claims for 399 patients. 75% of them were for generic drugs. CMS names the drug for 1,581 of them, across 24 drugs with 11 or more claims each, at $355,939 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Pradyumna Agasthi for performance year 2024, reported through an alternative payment model (APM). Pradyumna Agasthi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of coronary angioplasty and stenting by Pradyumna Agasthi, more than 52% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 62 papers to Pradyumna Agasthi, published from 2016 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Heart Failure, Percutaneous Coronary Intervention and Coronary Artery Disease. Pradyumna Agasthi has published most often in J Invasive Cardiol. Pradyumna Agasthi's most frequent co-authors are Reza Arsanjani, MD, Farouk Mookadam, MD and Chieh-Ju Chao, MD.

CMS Open Payments shows 123 general payments to Pradyumna Agasthi from 26 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 50% of the total. Boston Scientific Corporation paid the most, $2,090.